{
    "Trade/Device Name(s)": [
        "ImmunoCAP Total IgE System",
        "ImmunoCAP Total IgE Conjugate",
        "ImmunoCAP Total IgE Anti-IgE",
        "ImmunoCAP Total IgE Calibrators",
        "ImmunoCAP Total IgE Curve Controls",
        "ImmunoCAP Total IgE Control LMH"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "k133404",
    "Predicate Device Reference 510(k) Number(s)": [
        "k964152"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DGC",
        "JJX"
    ],
    "Summary Letter Date": "February 24, 2014",
    "Summary Letter Received Date": "February 5, 2014",
    "Submission Date": "February 4, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "allergy"
    ],
    "Analyte(s)": [
        "Total IgE"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated in vitro quantitative assay",
        "Fluorescence measurement"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "System",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Total IgE System and ImmunoCAP Total IgE Control LMH for quantitative measurement of total IgE in serum or plasma using Phadia instruments.",
    "Indications for Use Summary": "In vitro diagnostic system for quantitative measurement of circulating total IgE in human serum or plasma as an aid in diagnosing IgE mediated allergic disorders, used with Phadia 100, 250, 1000, 2500, or 5000 instruments.",
    "fda_folder": "Immunology"
}